Form 4: Checkpoint Therapeutics Director Michael Weiss Acquires Shares of Common Stock
SEC Form 4 Filing
Michael Weiss, a director at Checkpoint Therapeutics, acquired 82,051 shares of common stock on May 14, 2024, through restricted stock grants.
Summary
- On May 14, 2024, Michael Weiss, a director of Checkpoint Therapeutics, acquired 32,051 shares of restricted common stock that will vest on May 14, 2027, contingent upon his continued service on the board.
- He also acquired 50,000 shares of restricted common stock vesting in three equal installments on May 14, 2027, May 14, 2028, and May 14, 2029, also subject to continued board service.
- Following these transactions, Mr. Weiss directly owns 62,174 shares and indirectly owns 112,174 shares through Hawkins BioVentures, LLC, where he is the sole member.
Sentiment
Score: 6
Explanation: Neutral sentiment as it reflects routine insider transactions. The acquisition of shares by a director is generally viewed positively, but the vesting schedule is long-term.
Positives
- The acquisition of shares by a director signals confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Stakeholder Impact
- The increased ownership stake of a director could align interests with shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/14/2024 | Date of transaction: Acquisition of 32,051 and 50,000 shares of restricted common stock. |
| 05/14/2027 | Vesting date for 32,051 shares of restricted common stock and one-third of the 50,000 shares. |
| 05/14/2028 | Vesting date for one-third of the 50,000 shares of restricted common stock. |
| 05/14/2029 | Vesting date for the final one-third of the 50,000 shares of restricted common stock. |
| 05/16/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.